Published online Oct 24, 2024. doi: 10.5306/wjco.v15.i10.1264
Revised: August 25, 2024
Accepted: August 28, 2024
Published online: October 24, 2024
Processing time: 65 Days and 15.2 Hours
The prognosis of colorectal cancer (CRC) patients with peritoneal metastasis remains poor despite advancements in detection and treatment. Preoperative inflammatory and nutritional markers have emerged as significant predictors of prognosis in CRC, potentially guiding treatment decisions and improving patient outcomes. This editorial explores the prognostic value of markers such as the neutrophil-to-lymphocyte ratio, hemoglobin, and serum albumin levels. By integrating these markers into prognostic models, clinicians can better stratify patients, personalize treatment strategies, and ultimately enhance clinical outcomes. This review highlights the importance of these markers in providing a comprehensive assessment of patient condition and underscores the need for further research to validate their clinical utility and uncover underlying mecha
Core Tip: This editorial highlight the prognostic significance of preoperative inflammatory and nutritional markers, such as neutrophil-to-lymphocyte ratio, hemoglobin, and serum albumin, in colorectal cancer with peritoneal metastasis. By integrating these markers into prognostic models, we can improve the accuracy of prognosis prediction, guide personalized treatment strategies, and optimize patient outcomes. This comprehensive review underscores the need for further research to validate these findings and explore underlying mechanisms, ultimately enhancing the management of colorectal cancer.